Interpace Biosciences (IDXG) Profit Metrics
Price: $2.01
Market Cap: $8.83M
Avg Volume: 7.93K
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Interpace Biosciences's latest annual financial reports:
- The company has reported a gross profit of 23.04M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 57.30%, with a year-over-year growth of 26.39%.
- Interpace Biosciences's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.84M. The EBITDA margin stands at 9.54%, showing a growth of 201.48% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at 2.81M. The operating margin is 6.99%, with a year-over-year growth of 173.20%.
- The net income, which shows the company's total earnings or profit after all expenses, is 802.00K. The net profit margin is 1.99%, demonstrating a growth of 113.67% from the previous year.
These metrics provide a comprehensive overview of Interpace Biosciences's profitability and operational efficiency over the past year.
Gross Profit
$23.04M
Gross Profit Margin (2023)
57.30%
EBITDA
$3.84M
EBITDA Margin
9.54%
Operating Income (2023)
$2.81M
Operating Margin
6.99%
Net Income
$802.00K
Net Profit Margin
1.99%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Interpace Biosciences Historical Profit Metrics
Interpace Biosciences Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2023 | $23.04M | 26.39% | $2.81M | 173.20% | $802.00K | 113.67% | $3.84M | 201.48% |
| 2022 | $18.23M | 1.59% | $-3.84M | 67.28% | $-5.87M | 60.23% | $-3.78M | 53.79% |
| 2021 | $17.95M | 67.32% | $-11.74M | 55.80% | $-14.75M | 43.72% | $-8.18M | 62.17% |
| 2020 | $10.72M | 30.94% | $-26.55M | -10.96% | $-26.20M | 1.64% | $-21.63M | -7.68% |
| 2019 | $8.19M | -29.99% | $-23.93M | -97.48% | $-26.64M | -118.55% | $-20.09M | -183.61% |
| 2018 | $11.70M | 37.01% | $-12.12M | -92.58% | $-12.19M | 0.22% | $-7.08M | 34.24% |
| 2017 | $8.54M | 32.51% | $-6.29M | 2.31% | $-12.22M | -46.62% | $-10.77M | 3.45% |
| 2016 | $6.44M | 155.51% | $-6.44M | 84.06% | $-8.33M | 26.63% | $-11.15M | 56.97% |
| 2015 | $2.52M | -86.40% | $-40.41M | -199.99% | $-11.36M | 29.35% | $-25.93M | -186.12% |
| 2014 | $18.54M | -24.04% | $-13.47M | -214.94% | $-16.07M | -252.09% | $-9.06M | -217.71% |
| 2013 | $24.41M | -9.12% | $-4.28M | 83.05% | $-4.57M | 82.12% | $-2.85M | -111.30% |
| 2012 | $26.86M | -17.28% | $-25.23M | -436.62% | $-25.53M | -114.26% | $25.25M | 1637.64% |
| 2011 | $32.47M | 0.83% | $-4.70M | -9.22% | $-11.91M | -74.85% | $-1.64M | 33.44% |
| 2010 | $32.20M | 22.54% | $-4.30M | 89.39% | $-6.81M | 79.70% | $-2.47M | 45.47% |
| 2009 | $26.28M | 482.32% | $-40.58M | -11.39% | $-33.56M | 2.61% | $-4.52M | 84.40% |
| 2008 | $4.51M | -85.73% | $-36.43M | -155.09% | $-34.46M | -245.51% | $-29.01M | -281.17% |
| 2007 | $31.61M | -43.39% | $-14.28M | -341.50% | $-9.97M | -184.46% | $-7.61M | -156.59% |
| 2006 | $55.84M | -9.84% | $5.91M | 121.99% | $11.81M | 160.70% | $13.45M | 152.71% |
| 2005 | $61.94M | -37.33% | $-26.89M | -176.40% | $-19.45M | -192.06% | $-25.51M | -163.26% |
| 2004 | $98.83M | 10.94% | $35.19M | 79.64% | $21.13M | 72.39% | $40.33M | 45.59% |